Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dominik A. Barth"'
Autor:
Dominik A. Barth, Stefanie Stanzer, Jasmin Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Florian Posch, Rainer Lipp, Michael Halm, Joanna Szkandera, Marija Balic, Armin Gerger, Maria A. Smolle, Georg C. Hutterer, Christiane Klec, Philipp J. Jost, Julia Kargl, Martin Stradner, Martin Pichler
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3074-3083 (2022)
Abstract Background The presence of autoantibodies in the serum of cancer patients has been associated with immune‐checkpoint inhibitor (ICI) therapy response and immune‐related adverse events (irAEs). A prospective evaluation of different autoan
Externí odkaz:
https://doaj.org/article/8914eb1a50484886b516dc8999f59708
Autor:
Andrea Katharina Lindner, Martin Pichler, Sarah Maier, Hanno Ulmer, Thomas Gorreri, Anna Katharina Luger, Dominik A. Barth, Andreas Seeber, Florian Kocher, Renate Pichler
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is managed by radical or organ-sparing surgery. High recurrence rates require early detection and strict follow-up (FU) protocols. Recommendations are assigned to a low level of ev
Externí odkaz:
https://doaj.org/article/7eb421c2f13f4f63b81fb69143fb53e1
Autor:
Hannah Fluhrer, Georg C. Hutterer, Sylvia Golbeck, Michael Stidl, Tobias Niedrist, Renate Pichler, Johannes Mischinger, Maximilian Seles, Sebastian Mannweiler, Jasmin Spiegelberg, Thomas Bauernhofer, Philipp J. Jost, Sascha Ahyai, Richard Zigeuner, Martin Pichler, Dominik A. Barth
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: The treatment landscape of metastatic renal cell carcinoma (mRCC) has substantially advanced over the last three decades, whereby data from controlled clinical trials indicate significant improvements regarding patients’ overall surviva
Externí odkaz:
https://doaj.org/article/1ad8615ac9ab434590e72d3eae997bc7
Autor:
Florian Posch, Felix Prinz, Amar Balihodzic, Christian Mayr, Tobias Kiesslich, Christiane Klec, Katharina Jonas, Dominik A. Barth, Jakob M. Riedl, Armin Gerger, Martin Pichler
Publikováno v:
Cancers, Vol 13, Iss 16, p 3996 (2021)
Biliary tract cancer is a major global health issue in cancer-related mortality. Therapeutic options are limited, and cisplatin-based treatment schedules represent the mainstay of first-line therapeutic strategies. Although the gain of survival by th
Externí odkaz:
https://doaj.org/article/3bcaa709e5d644aaae244edb2c9d3df9
Publikováno v:
Cancers, Vol 13, Iss 5, p 977 (2021)
The rapid and uncontrolled proliferation of cancer cells is supported by metabolic reprogramming. Altered glucose metabolism supports cancer growth and progression. Compared with normal cells, cancer cells show increased glucose uptake, aerobic glyco
Externí odkaz:
https://doaj.org/article/3fb96b18e10146ceb63b9d217b19b412
Autor:
Jakob M. Riedl, Dominik A. Barth, Wolfgang M. Brueckl, Gloria Zeitler, Vasile Foris, Stefanie Mollnar, Michael Stotz, Christopher H. Rossmann, Angelika Terbuch, Marija Balic, Tobias Niedrist, Thomas Bertsch, Herbert Stoeger, Martin Pichler, Horst Olschewski, Gudrun Absenger, Joachim H. Ficker, Armin Gerger, Florian Posch
Publikováno v:
Cancers, Vol 12, Iss 8, p 2319 (2020)
Background: Biomarkers for predicting response to immune checkpoint inhibitors (ICI) are scarce and often lack external validation. This study provides a comprehensive investigation of pretreatment C-reactive protein (CRP) levels as well as its longi
Externí odkaz:
https://doaj.org/article/7a011e683c4b485e91f27985bb876531
Publikováno v:
Cancers, Vol 12, Iss 8, p 2148 (2020)
Available systemic treatment options for cancers of the genitourinary system have experienced great progress in the last decade. However, a large proportion of patients eventually develop resistance to treatment, resulting in disease progression and
Externí odkaz:
https://doaj.org/article/a9d3571759d646f08248c0eaf3070747
Autor:
Michael Stotz, Dominik A. Barth, Jakob M. Riedl, Eva Asamer, Eva V. Klocker, Peter Kornprat, Georg C. Hutterer, Felix Prinz, Karoline Lackner, Herbert Stöger, Armin Gerger, Martin Pichler
Publikováno v:
Cancers, Vol 12, Iss 7, p 1798 (2020)
Pancreatic enzymes might play a pivotal role in the pathophysiology and prognosis of pancreatic cancer. The aim of this study is to investigate the lipase/amylase ratio (LAR), representing a marker previously used in the differentiation of pancreatit
Externí odkaz:
https://doaj.org/article/e1e6ae7c35974fdbb3ac0db51fdec016
Autor:
Maximilian Seles, Georg C. Hutterer, Johannes Foßelteder, Marek Svoboda, Margit Resel, Dominik A. Barth, Renate Pichler, Thomas Bauernhofer, Richard E. Zigeuner, Karl Pummer, Ondrej Slaby, Christiane Klec, Martin Pichler
Publikováno v:
Cancers, Vol 12, Iss 5, p 1200 (2020)
POU3F3 adjacent non-coding transcript 1 (PANTR1) is an oncogenic long non-coding RNA with significant influence on numerous cellular features in different types of cancer. No characterization of its role in renal cell carcinoma (RCC) is yet available
Externí odkaz:
https://doaj.org/article/2ce599ac3ed14e7c9aae2bf6c3c8cef6
Autor:
Dominik A. Barth, Ondrej Slaby, Christiane Klec, Jaroslav Juracek, Rares Drula, George A. Calin, Martin Pichler
Publikováno v:
Cancers, Vol 11, Iss 10, p 1580 (2019)
Renal cell carcinoma (RCC) is a relatively rare malignancy of the urinary tract system. RCC is a heterogenous disease in terms of underlying histology and its associated underlying pathobiology, prognosis and treatment schedule. The most prevalent hi
Externí odkaz:
https://doaj.org/article/4b8f563bcf73446d9dd7c24c2194a12c